Max Robotics — Global Service Robot Directory + US Certification

About

Dr. Jason A. Efstathiou is a leading genitourinary oncologist and radiation oncologist whose work centers on advancing treatment for muscle-invasive and metastatic bladder cancer, as well as optimizing radiotherapy techniques for prostate cancer. He is a key contributor to the European Association of Urology (EAU) Guidelines on Muscle-invasive and Metastatic Bladder Cancer, with the 2023 edition alone garnering over 611 citations—a testament to its global influence on clinical practice. Dr. Efstathiou’s research bridges translational science and clinical innovation, including pioneering work on drug screening platforms to identify molecular targeted radiosensitizers linked to genomic biomarkers, and exploring insurance coverage challenges for proton therapy, highlighting his commitment to both scientific rigor and healthcare accessibility. His technical contributions include dosimetric validation of robotic prostate stereotactic body radiotherapy (SBRT) with MRI-guided dose escalation to dominant intraprostatic lesions, advancing precision in radiation oncology. With a career defined by high-impact guidelines, translational discoveries, and patient-centered advocacy, Dr. Efstathiou remains a pivotal figure shaping the future of urologic oncology.